Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.

Expert Review of Hematology
Alessandro AllegraCaterina Musolino

Abstract

Introduction: Cognitive impairment caused by chemotherapies, a condition known as chemobrain, is a possible side effect that affects alertness, learning, memory, and concentration.Areas covered: Chemobrain has been principally investigated as a possible side-effect among cancer patients. However, numerous drugs used to treat hematological malignancies can determine the appearance of chemobrain. In this review, we have examined some commonly used drugs for the treatment of hematological malignancies which are known to have a deleterious action on cognitive functions.Numerous mechanisms have been suggested, comprising the direct neurotoxicity of chemotherapeutic drugs, oxidative stress, genetic predisposition, cytokine-provoked damage, histone modifications, immune alteration, and the action of chemotherapeutic on trophic factors and structural proteins of brain cells.Expert commentary: Cognitive dysfunction provoked by the treatment of hematological diseases is an actual challenge in clinical practice. Actually, there are no totally efficient and innocuous treatments for this syndrome. It is important that further investigations specify the existence of predictors and gravity factors to pre- and post-therapy cognitive change and...Continue Reading

References

Nov 1, 1986·Annals of Neurology·P C PhillipsD A Rottenberg
Aug 25, 2001·Annual Review of Neuroscience·E J Huang, L F Reichardt
Jan 28, 2003·Journal of Neuroscience Research·Christian Lefebvre d'HellencourtDominique Couez
Apr 8, 2003·Current Pharmaceutical Design·Weihong Pan, Abba J Kastin
Jan 7, 2004·Clinical Breast Cancer·Joyce A O'Shaughnessy
May 8, 2004·Experimental Gerontology·Karen Suárez KrabbeHelle Bruunsgaard
Jul 22, 2004·Behavioural Brain Research·Daniela BraidaMariaelvina Sala
Nov 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jenny HsiehFred H Gage
Jun 2, 2005·Journal of the National Cancer Institute·Lara H HeflinMargaret Gatz
Jun 21, 2005·Brain, Behavior, and Immunity·Karen Suárez KrabbeHelle Bruunsgaard
Aug 5, 2005·The New England Journal of Medicine·Charles A CzeislerUNKNOWN U.S. Modafinil in Shift Work Sleep Disorder Study Group
Nov 22, 2005·Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society·John Michael HoldenLisa Matthews
May 16, 2006·Neurobiology of Disease·Jitbanjong TangpongD Allan Butterfield
May 19, 2007·Behavioural Brain Research·Jill E MacleodDavid J Bucci
Jun 5, 2007·Biochimie·Mounira K Chelbi-Alix, Juana Wietzerbin
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J VardyS B Schagen
Nov 10, 2007·Current Opinion in Neurology·George KannarkatDavid Schiff
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Apr 16, 2008·International Journal of Radiation Oncology, Biology, Physics·Clifton D FullerMartin Fuss
Aug 5, 2008·Neurobiology of Aging·Fabio SambataroVenkata S Mattay
Aug 12, 2009·Neurobiology of Disease·William A Banks, Michelle A Erickson
Oct 9, 2009·Journal of Psychosocial Oncology·Stephanie A Reid-ArndtCatherine Hsieh
Nov 10, 2009·Lancet·Carole SoussainJean-Yves Delattre
Jul 30, 2010·Human Brain Mapping·Michiel B de RuiterSanne B Schagen
Sep 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heather M ConklinRaja B Khan
Jan 22, 2011·Psycho-oncology·Florence JolyBénédicte Giffard
Apr 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L RubensteinPaul J Stewart
May 31, 2011·Behavioural Brain Research·Michelle Monje, Jörg Dietrich
Aug 5, 2011·Clinical Pharmacology and Therapeutics·J E FardellG Winocur
Oct 13, 2011·American Journal of Hematology·Maria Christina CoxMaria Antonietta Aloe Spiriti
Nov 17, 2011·European Journal of Haematology·Mauro CivesFranco Silvestris
Dec 6, 2011·Behavioural Brain Research·Ross ZeitlinValentina Echeverria

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology
Gyongyver SzentmartoniMagdolna Dank
Cancer Investigation
Arti HurriaTim Ahles
© 2021 Meta ULC. All rights reserved